Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diphenoxylate hydrochloride + atropine sulfate is a fixed-dose oral combination medication used to treat diarrhea. Diphenoxylate is an opioid derivative that acts as an antidiarrheal by slowing intestinal motility through agonism of the mu opiate receptor, thereby reducing bowel contractions and prolonging transit time. Atropine sulfate, an anticholinergic agent acting as a muscarinic acetylcholine receptor antagonist, is included in subtherapeutic amounts to discourage abuse by causing unpleasant side effects at higher doses. The combination was approved for medical use in the United States in 1960 and remains widely prescribed for severe diarrhea[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diphenoxylate hydrochloride + atropine sulfate.